Odyssean LLC’s Cidara Therapeutics CDTX Stock Holding History

Odyssean LLC’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,358	Closed	-$300K	–	431
2025 Q4	$300K	Buy	+1,358	New	+$219K	0.22%	197

Odyssean LLC's CDTX Position: Q1 2026 in Review

Odyssean LLC sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 1,358 shares — an estimated $300K sold.

Odyssean LLC first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $300K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Odyssean LLC reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Odyssean LLC sold 1,358 Cidara Therapeutics shares in Q1 2026, an estimated $300K.
Odyssean LLC first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Odyssean LLC's Cidara Therapeutics position peaked at $300K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Odyssean LLC's 13F filing for Q1 2026, filed 15 May 2026.